THERAPEUTIC CLASS

Cardiovascular outcomes in diabetic kidney disease: insights from recent clinical trials

---

The prevalence of type 2 diabetes is catalyzing a pandemic in kidney disease, with ensuing cardiovascular complications. The effort to identify antidiabetic agents capable of promoting benefits that go beyond the bounds of glucose control has produced remarkable outcomes in
recent cardiovascular outcomes trials in patients with type 2 diabetes mellitus, many of whom have diabetic kidney disease.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Cardiovascular & Hematopoietic System
Endocrine & Metabolic system

Specific Detail Info

Kidney International Supplements (2018) 8, 8–17;

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment